Anti-IL-17A treatment reduces serum inflammatory, angiogenic and tissue remodeling biomarkers accompanied by less synovial high endothelial venules in peripheral spondyloarthritis
Merlijn H. Kaaij(Amsterdam University Medical Centers), Sander W. Tas(Amsterdam UMC Location University of Amsterdam)
Cited by 15
Related Papers
Local treatment with the selective IκB kinase β inhibitor NEMO-binding domain peptide ameliorates synovial inflammation
|Arthritis Research & Therapy|2006|74
Tertiary Lymphoid Structures in Rheumatoid Arthritis
|American Journal Of Pathology|2015|43